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Abstract 
 
 
 
 
 
 
 
Digestive cancer represents a severe public health problem, being one of the main 
causes of death. It is considered a multifactorial disease, with hereditary predisposition, 
environmental factors, and other factors involved in carcinogenesis. Both the evolution and 
the pathogenesis of digestive neoplasms remain incompletely elucidated. As a multifactorial 
disease, it can be approached by taking into account the biopsychosocial influences via 
enteric nervous system. Many peptides and non-peptides having a neurotransmitter role can 
be found in the enteric nervous system, which can influence the neoplastic process directly 
or indirectly by affecting some angiogenic, growth, and metastasis factors. However, 
neurotransmitters can also cause directly, through intercellular signalizing, the angiogenesis, 
the proliferation, and the digestive neoplasms’ metastasis. This new approach to neoplasms 
of the digestive tube assumes broader psychosocial factors can play an important role in the 
understanding the ethiopathogenie, the evolution of the disease, and determination of 
possible molecular targeted therapies; it also suggests that behavioral strategies may be 
important for maintaining a healthy state with respect to the digestive tract. 
  
Keywords: enteric nervous system, neurotransmitters, carcinogenesis, 
biopsychosocial influences 
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Introduction 
Digestive cancer represents a serious public 
health problem. Epidemiologically 20% of the 
cancers involve the digestive tract, and this 
represents over 25% of the deaths caused by cancer 
(1). Digestive cancer is considered a multifactorial 
disease, with hereditary predisposition, 
environmental factors and other factors involved in 
carcinogenesis. Both the evolution and the 
pathogenesis of digestive neoplasms remain 
incompletely elucidated. 
On the other hand, currently there is a trend of 
replacing the disease’s classic etiological pattern 
with a view that assumes a biopsychosocial 
approach. Although the idea of the mind playing a 
role in the etiology of diseases was initially 
marginalized, Western medicine is increasingly 
viewing the mind and the body as linked within an 
integrated system, the disorder of which causes pain 
(the way a person detects changes in his health 
condition) and disease (2). According to 
biopsychosocial view, symptoms, despite the fact 
they can have a multiple pathophysiological 
determinism, can be affected by both the 
sociocultural and psychological influences (3). This 
idea is not new: the approach of making 
connections between the psychological influences 
and cancer originates from the Greek doctor Galen, 
who in the Ian century before Christ observed that 
so called melancholic women developed breast 
cancer more frequently than those with the other 
behavioral types (4). 
Many studies have described both the 
involvement of the nervous system in the 
modulation of tumor progression and the possible 
signalizing mechanisms from tumors to nervous 
system (5,6,7). Despite this, much remains 
unexplained. Here we attempt to highlight some of 
the interactions between the central nervous system 
and digestive tract carcinogenesis. This new way of 
understanding the initiation, progression and tumor 
metastasis, represents in biopsychosocial terms, a 
new way to approach and manage the disease. This 
paper attempts to demonstrate the pathophysiologic 
substrate which is under the influence of the 
nervous system, the center of all mental 
activities/processes. 
 
Discussion 
Brain-gastrointestinal tract axis 
The gastrointestinal tract has its own nervous 
system called the enteric nervous system. This 
system is entirely disposed in the intestinal wall, 
starting from the esophagus to the anus. About 100 
million neurons are part of the enteric nervous 
system, almost the same number as in the spinal 
cord (8). However, there are also other neuronal 
networks which control the digestive functions, 
networks that are ordered in four main levels of 
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integrative organization (2). If the first level is 
represented by the enteric nervous system, the 
second level is the paraspinal sympathetic ganglia, 
where peripheral reflex arcs are influenced by 
sympathetic preganglionic fibers, which originate 
from the spinal cord. The next two levels are part of 
the central nervous system. At the third level, 
sympathetic and parasympathetic efferents towards 
the intestine are caused, at least partially, by 
reflexes with the afferent arc represented by sensory 
fibers which follow the path of autonomous nerves. 
The fourth level is represented by superior nervous 
centers that generate descendant signals, which are 
integrated with the sensory afferent signals at the 
third level (9).  
Neurotransmitters and digestive cancer 
Many peptides and non-peptides having a 
neurotransmitter role are found in the enteric 
nervous system (10). Recent studies usingimmune-
histochemicalmethods have identified 
neurotransmitters for some neurons in 
gastrointestinal tract, their presence or their absence 
representing a method of classifying the enteric 
neurons (11). In attempt to deepen the 
understanding of the multiple functions of the 
enteric nervous system, researchers worldwide have 
identified more than twelve substances acting as 
neurotransmitters, substances that are being 
released from the different enteric neurons endings 
(8). Among these are: acetylcholine, 
norepinephrine, adenosine triphosphate, serotonin, 
dopamine, cholecystokinin, P substance, vasoactive 
intestinal polypeptide, somatostatin, leuenkefalina, 
metenkefalina and bombesin. The actions of many 
of theseare not sufficiently well known (8). 
Due to the link between nervous elements and 
blood vessels in tumor tissues, and to the influence 
of certain neurotransmitters on tumor cells, some 
authors refer to a neuro-neoplasic synapse 
(12,13,14). Via some neurotransmitters, locally 
released stimulating or inhibitory influences over 
the activity of neoplastic cells may exist. On the 
other hand, changing the balance between 
stimulating and inhibitory neurotransmitters can 
confirm this assumption (15). 
The influence of neurotransmitters on the 
neoplastic process can be exercised directly or 
indirectly by affecting elements of angiogenic, 
growth and metastasis factors. But 
neurotransmitters can cause directly, through 
intercellular signalizing, the angiogenesis, the 
proliferation and the digestive neoplasm’s 
metastasis (15). 
In vitro studies show that norepinephrine, 
dopamine and P substance increase the proliferation 
rate of cells in colon neoplasm (12,16). 
Catecholamines act on the digestive system by 
stimulating beta-adrenergic receptors. This binding 
is responsible for the activation of adenylatecyclase 
via Gs protein, which is responsible for the 
increasing the intracellular concentration of AMPc 
(17). This acts like a signal or second messenger 
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transducer which changes, in turn, the percentage of 
several enzyme-catalyzed reactions. The final result 
is represented by the upregulation of angiogenetic 
factors (18,19). 
Angiogenesis is a complex process that 
includes several stages, each having an important 
role in the progression and metastasis of digestive 
neoplasms (20). Several factors initiate and sustain 
this process: VEGF (vascular endothelial growth 
factor), bFGF (basic fibroblast growth factor), 
aFGF (acidic fibroblast growth factor), PDGF 
(patelet-derived growth factor), HGF (hepatocyte 
growth factor), Ang-1 (angiopoietin-1), but also 
other factors which can be involved in the 
angiogenesis cascade (21). The most important 
factor is VEGF, with many studies indicating an 
overexpression of the vascular endothelial factor, 
which appears after the stimulation of beta2 
adrenergic receptors (22-26). 
Metalloproteinases represent another protein 
group with enzymatic activity which leads to the 
progression and metastatis of digestive neoplasms 
(27). Their primary role is to degrade the tissue 
from the tumoral microenvironment that allows, on 
one hand, tumoral progression and, on the other 
hand, remodeling tissues among blood vessels 
(28,29). Their level, as well as the level of VEGF, 
can be increased by stimulating beta-adrenergic 
receptors (17). 
On the other hand, acetylcholine can cause 
directly or indirectly, the overexpression of some 
growth, angiogenic and proliferation factors in 
neoplastic cells (30,31,32). Noteworthy is that 
acetylcholine, by activating M3 muscarinic 
receptors and by stimulating metalloproteinase-7 
(MMP-7), can cleave heparin binding epidermal 
growth factor receptors (HB-EGF) from Pro-HB-
EGF (33). A way of intercellular signalizing is thus 
activated which results in the transcription of some 
genes responsible foruncontrolled proliferation and 
of  the avoidance of apoptosis by neoplastic cells 
(34,35,36). 
Besides the neurotransmitters mentioned 
above, others are also found. Several studies show 
that surgical or chemical denervation of different 
segments of the digestive tract negatively influence 
carcinogenesis at that level (37,38). 
Psychological factors and neoplasm 
Many neurotransmitters implicated in 
carcinogenesis are also associated with negative 
psychological factors, which themselves may be 
relevant factors for the patient’s health. The past 
decades have been characterized by a progressing 
interest regarding stress’ effects over the 
gastrointestinal tract, as explored in both human and 
animal studies (39). In rodents, stress affects hydric 
homeostasis and natural defense barriers, and it 
increases the permeability of mucous, allowing 
their penetration by bacteria (40). Clinical studies 
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show that negative psychological factors affect the 
onset, promotion, progression, and metastasis of 
tumors (41). Studies also show that through 
sympathetic nervous mechanisms and through the 
chronic activation of hypothalamic-pituitary-
adrenal axis, the immune response is affected. In 
this way, deficiencies in the DNA repairing 
mechanisms appear, with the alteration of the 
function of some important genes implicated in 
cellular replication and in apoptosis (42). It has 
been observed that drugs such as adrenergic system 
blockers or prostaglandins reduce the effects 
mediated by stress in carcinogenesis (43). 
Brain-mast cell axis in malignant tumors of 
digestive tract 
Currently, the connection between brain and 
mast cell provides a more plausible mechanism to 
explain the evident relation between stress and 
defining symptoms of irritable bowel syndrome (2). 
Inflammatory mediators released by these cells 
access and influence ENS, via paracrine changes of 
electric and synaptic behavior of enteric neurons 
(44). Evidence of brain-mast cell connection is 
offered by the Pavlovian conditioning possibility of 
mast cells degranulation (45). The influence of the 
CNS over the mast cells from the superior digestive 
tract is also suggested by the increasing 
concentration of histamine at their level when the 
vagus nerve is being stimulated (46). Electrical 
stimulation of spinal afferents in the small intestine 
causes histamine releasing from mast cells, an 
effect mediated by P substance’s action on 
neurokinin-1receptor, which is being expressed on 
the surface of mast cells (47, 48). 
Studies have also demonstrated that mast cells 
play an important role in carcinogenesis by 
releasing inflammatory cytokines which affect 
tumor progression, angiogenesis, and metastasis 
(49). In 2009, research suggested that mast cells can 
be the target of neoplastic therapy (50). More 
recently in 2010, the infiltration of pancreatic 
tumors with mast cells has been associated with a 
poor prognosis (51). Another study performed in 
the same year showed that gastric cancer malignity 
is correlated with tumor and peritumoral infiltration 
degree with mast cells (52). 
 
Conclusions 
Cancer of the digestive tube represents one of 
the major problems currently facing society. This 
multifactorial disease and may be best studied by 
taking into account the biopsychosocial 
influencesvia enteric nervous system.The enteric 
nervous system is permanently linked not only with 
the central nervous system, but also with the other 
neuronal networks such as sympathetic and 
parasympathetic autonomic nervous system. 
Influences of the central nervous system (both 
those sociocultural and psychological) can be 
reflected in the carcinogenesis process through both 
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the interaction with the enteric nervous system and 
through mast cells.This new approach to neoplasms 
of the digestive tube plays an important role in the 
understanding the ethiopathogenesis, the evolution 
of the disease, determination of possible molecular 
targeted therapies and also determination of some 
behavioral cues for sustaining good health status. 
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